Cytokine-secreting tumor cell vaccines

被引:104
作者
Mach, N [1 ]
Dranoff, G [1 ]
机构
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0952-7915(00)00144-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Modification of the tumor microenvironment with gene transfer techniques stimulates two immune mechanisms that effectuate tumor destruction. One involves improved tumor-antigen presentation for the development of specific cellular and humoral immunity. The second involves compromise of the tumor vasculature by soluble factors and leukocytes.
引用
收藏
页码:571 / 575
页数:5
相关论文
共 59 条
[1]  
AbdelWahab Z, 1997, CANCER, V80, P401, DOI 10.1002/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO
[2]  
2-U
[3]   Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells [J].
Arienti, F ;
Belli, F ;
Napolitano, F ;
Sulé-Suso, J ;
Mazzocchi, A ;
Gallino, GF ;
Cattelan, A ;
Sanantonio, C ;
Rivoltini, L ;
Melani, C ;
Colombo, MP ;
Cascinelli, N ;
Maio, M ;
Parmiani, G .
HUMAN GENE THERAPY, 1999, 10 (18) :2907-2916
[4]   Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells [J].
Arienti, F ;
SuleSuso, J ;
Belli, F ;
Mascheroni, L ;
Rivoltini, L ;
Melani, C ;
Maio, M ;
Cascinelli, N ;
Colombo, MP ;
Parmiani, G .
HUMAN GENE THERAPY, 1996, 7 (16) :1955-1963
[5]  
Aruga A, 1997, CANCER RES, V57, P3230
[6]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[7]  
BASOMBRIO MA, 1970, CANCER RES, V30, P2458
[8]   Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: Evaluation of efficacy and tolerability [J].
Belli, F ;
Arienti, F ;
SuleSuso, J ;
Clemente, C ;
Mascheroni, L ;
Cattelan, A ;
Sanantonio, C ;
Gallino, GF ;
Melani, C ;
Rao, S ;
Colombo, MP ;
Maio, M ;
Cascinelli, N ;
Parmiani, G .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (04) :197-203
[9]   Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of HER-2/neu transgenic mice [J].
Boggio, K ;
Nicoletti, G ;
Di Carlo, E ;
Cavallo, F ;
Landuzzi, L ;
Melani, C ;
Giovarelli, M ;
Rossi, I ;
Nanni, P ;
De Giovanni, C ;
Bouchard, P ;
Wolf, S ;
Modesti, A ;
Musiani, P ;
Lollini, PL ;
Colombo, MP ;
Forni, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) :589-596
[10]   IL-2 adenovector-transduced autologous tumor cells reduce antitumor immune responses in patients with neuroblastoma [J].
Bowman, L ;
Grossmann, M ;
Rill, D ;
Brown, M ;
Zhong, WY ;
Alexander, B ;
Leimig, T ;
Coustan-Smith, E ;
Campana, D ;
Jenkins, J ;
Woods, D ;
Kitchingman, G ;
Vanin, E ;
Brenner, M .
BLOOD, 1998, 92 (06) :1941-1949